Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry po...
Q1 2026
May 11, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 3, 2025
Q2 2025
Aug 12, 2025